102 related articles for article (PubMed ID: 9074521)
1. Iodine-131 therapy in sporadic nontoxic goiter.
de Klerk JM; van Isselt JW; van Dijk A; Hakman ME; Pameijer FA; Koppeschaar HP; Zelissen PM; van Schaik JP; van Rijk PP
J Nucl Med; 1997 Mar; 38(3):372-6. PubMed ID: 9074521
[TBL] [Abstract][Full Text] [Related]
2. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic versus scintigraphic measurement of thyroid volume in patients referred for 131I therapy.
Wesche MF; Tiel-van Buul MM; Smits NJ; Wiersinga WM
Nucl Med Commun; 1998 Apr; 19(4):341-6. PubMed ID: 9853324
[TBL] [Abstract][Full Text] [Related]
4. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function.
Bonnema SJ; Bertelsen H; Mortensen J; Andersen PB; Knudsen DU; Bastholt L; Hegedüs L
J Clin Endocrinol Metab; 1999 Oct; 84(10):3636-41. PubMed ID: 10523007
[TBL] [Abstract][Full Text] [Related]
5. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.
Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE
Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine therapy for thyroid volume reduction of large goitres.
Bachmann J; Kobe C; Bor S; Rahlff I; Dietlein M; Schicha H; Schmidt M
Nucl Med Commun; 2009 Jun; 30(6):466-71. PubMed ID: 19381116
[TBL] [Abstract][Full Text] [Related]
7. [Can radioactive iodine be used in the treatment of diffuse non-toxic goiter?].
Nygaard B; Hegedüs L; Bennedbaek FN; Veje A; Faber JO; Hansen JE
Ugeskr Laeger; 1998 Sep; 160(37):5349-52. PubMed ID: 9748860
[TBL] [Abstract][Full Text] [Related]
8. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine for nontoxic multinodular goiter.
Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic estimation of thyroid volume and dose distribution at treatment with 131I.
Olsen KJ
Acta Radiol Oncol Radiat Phys Biol; 1978; 17(1):74-80. PubMed ID: 696403
[TBL] [Abstract][Full Text] [Related]
12. 131I therapy of toxic and non-toxic goiters.
Beckers C
Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter.
Wesche MF; Tiel-V Buul MM; Lips P; Smits NJ; Wiersinga WM
J Clin Endocrinol Metab; 2001 Mar; 86(3):998-1005. PubMed ID: 11238476
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine treatment of Plummer and multinodular toxic and nontoxic goiter disease by the first approximation dosimetry method.
Zingrillo M; Urbano N; Suriano V; Modoni S
Cancer Biother Radiopharm; 2007 Apr; 22(2):256-60. PubMed ID: 17600473
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
[TBL] [Abstract][Full Text] [Related]
19. Therapy of large multinodular goitre using repeated doses of radioiodine.
Baczyk M; Pisarek M; Czepczyński R; Ziemnicka K; Gryczyńska M; Pietz L; Sowiński J
Nucl Med Commun; 2009 Mar; 30(3):226-31. PubMed ID: 19262285
[TBL] [Abstract][Full Text] [Related]
20. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative?
Bertelsen J; Herskind AM; Sprogøe Jakobsen U; Hegedüs L
Thyroidology; 1992 Dec; 4(3):103-6. PubMed ID: 1285034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
